Kevin A. O’Connor was quoted in the Law360 article "PTAB's Doors Would Be Closed to Generics Under Hatch Bill," published on June 20, 2018. In the article, Kevin discusses how the proposed legislation would impact the generic drug approval process.

Click here to read the article.